Title: HOUSE BILL 1315
Official Title: HOUSE BILL 1315
Number of Sections: 1
Source: versions - Third - Vaccinations by Pharmacists and Health Insurance Coverage for Immunizations
Media Type: application/pdf
Strikethrough Detection: 6 sections found

================================================================================

Section 1:
J5, J1 5lr2486
By: Delegates Guzzone, Pena–Melnyk, Barnes, Crutchfield, Cullison, Embry, Fair,
Forbes, Harris, Hill, Kaiser, R. Lewis, Lopez, Martinez, Palakovich Carr,
Pruski, Ruff, Schindler, Smith, Stewart, Terrasa, Williams, and Woorman
Woorman, Alston, Bagnall, Bhandari, S. Johnson, Kerr, Rosenberg, Ross,
Taveras, White Holland, and Woods
Introduced and read first time: February 7, 2025
Assigned to: Health and Government Operations
Committee Report: Favorable with amendments
House action: Adopted
Read second time: March 6, 2025
CHAPTER ______
1 AN ACT concerning
2 Health Insurance – Vaccinations by Pharmacists and Health Insurance
3 Coverage for Child Wellness Services – Immunizations
4 FOR the purpose of altering the vaccinations that a pharmacist may administer, subject to
5 certain requirements, to an individual of at least a certain age; altering the
6 vaccinations included in the minimum package of child wellness services for which
7 certain health insurers and nonprofit health service plans are required to provide
8 coverage; and generally relating to health insurance coverage for child wellness
9 services immunizations.
10 BY repealing and reenacting, with amendments,
11 Article – Health Occupations
12 Section 12–508
13 Annotated Code of Maryland
14 (2021 Replacement Volume and 2024 Supplement)
15 BY repealing and reenacting, without amendments,
16 Article – Insurance
17 Section 15–817(a), (b), and (f)
18 Annotated Code of Maryland
19 (2017 Replacement Volume and 2024 Supplement)
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment. *hb1315*
2 HOUSE BILL 1315
1 BY repealing and reenacting, with amendments,
2 Article – Insurance
3 Section 15–817(c)
4 Annotated Code of Maryland
5 (2017 Replacement Volume and 2024 Supplement)
6 BY adding to
7 Article – Insurance
8 Section 15–817(g)
9 Annotated Code of Maryland
10 (2017 Replacement Volume and 2024 Supplement)
11 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
12 That the Laws of Maryland read as follows:
13 Article – Health Occupations
14 12–508.
15 (a) (1) Subject to paragraph (4) of this subsection, a pharmacist may order and
16 administer a vaccination to an individual who is at least 3 years old if:
17 (i) The vaccine is:
18 1. An influenza vaccine;
19 2. A COVID–19 vaccine; or
20 3. Used in response to a public health emergency;
21 (ii) The pharmacist has completed a practical training program of at
22 least 20 hours that is approved by the Accreditation Council for Pharmacy Education and
23 includes:
24 1. Hands–on injection techniques;
25 2. Clinical evaluation of indications and contraindications of
26 vaccines; and
27 3. The recognition and treatment of emergency reactions to
28 vaccines;
29 (iii) The pharmacist has a current certificate in basic
30 cardiopulmonary resuscitation;
HOUSE BILL 1315 3
1 (iv) The pharmacist has completed a minimum of 2 hours of
2 continuing pharmaceutical education related to immunizations that is approved by the
3 Accreditation Council for Pharmacy Education as part of the license renewal requirements
4 under § 12–309 of this title;
5 (v) The pharmacist complies with the record–keeping and reporting
6 requirements in paragraph (5) of this subsection and any corresponding regulations
7 adopted by the Board; and
8 (vi) If the vaccination is administered to an individual under the age
9 of 18 years, the pharmacist informs the child vaccination patient and adult caregiver who
10 is accompanying the child of the importance of well–child visits with a pediatric primary
11 care provider and refers the patient to a pediatric primary care provider when appropriate.
12 (2) Subject to paragraph (4) of this subsection, a pharmacist who has met
13 the requirement of paragraph (1)(ii) through (vi) of this subsection may administer to an
14 individual who is at least 7 years old a vaccination that is:
15 (i) Recommended by the Centers for Disease Control and
16 Prevention’s Advisory Committee on Immunization Practices; or
17 (ii) Approved or authorized by the U.S. Food and Drug
18 Administration.
19 (3) Subject to paragraph (4) of this subsection, a pharmacist who has met
20 the requirement of paragraph (1)(ii), (iii), and (iv) of this subsection may administer to an
21 adult a vaccination that is recommended in the Centers for Disease Control and
22 Prevention’s Health Information for International Travel.
23 (4) (I) A pharmacist shall administer a vaccination under paragraph
24 (1), (2), or (3) of this subsection under a written protocol that:
25 [(i)] 1. Is vaccine specific; and
26 [(ii)] 2. Meets criteria established by the Department, in
27 consultation with the Board, the Board of Physicians, and the Board of Nursing, in
28 regulation.
29 (II) THE RECOMMENDATIONS OF THE CENTERS FOR DISEASE
30 CONTROL AND PREVENTION’S ADVISORY COMMITTEE ON IMMUNIZATION
31 PRACTICES CITED IN THIS SECTION REFER TO FEDERAL STATUTES, RULES, AND
32 GUIDANCE IN EFFECT:
33 1. ON DECEMBER 31, 2024; OR
4 HOUSE BILL 1315
1 2. AT A LATER DATE TO ACCOUNT FOR ANY NEW
2 VACCINES RECOMMENDED BY THE CENTERS FOR DISEASE CONTROL AND
3 PREVENTION’S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES AFTER
4 DECEMBER 31, 2024.
5 (5) A pharmacist shall:
6 (i) Report all vaccinations administered by the pharmacist to the
7 ImmuNet Program established under § 18–109 of the Health – General Article;
8 (ii) If the vaccination has been administered in accordance with a
9 prescription, document at least one effort to inform the individual’s authorized prescriber
10 that the vaccination has been administered; and
11 (iii) Except for an influenza vaccination administered under
12 paragraph (1) of this subsection, if the authorized prescriber is not the individual’s primary
13 care provider or if the vaccination has not been administered in accordance with a
14 prescription, document at least one effort to inform the individual’s primary care provider
15 or other usual source of care that the vaccination has been administered.
16 (b) The Board shall:
17 (1) Set reasonable fees for the administration of vaccinations under this
18 section; and
19 (2) Adopt regulations that require a pharmacist to submit a registration
20 form to the Board that includes verification that the pharmacist:
21 (i) Has successfully completed a certification course approved by the
22 Board that included instruction in the guidelines and recommendations of the Centers for
23 Disease Control and Prevention regarding vaccinations IN EFFECT ON DECEMBER 31,
24 2024; and
25 (ii) Is certified in basic cardiopulmonary resuscitation and obtained
26 the certification through in–person classroom instruction.
27 Article – Insurance
28 15–817.
29 (a) In this section, “child wellness services” means preventive activities designed
30 to protect children from morbidity and mortality and promote child development.
31 (b) This section applies to each individual hospital or major medical insurance
32 policy, group or blanket health insurance policy, and nonprofit health service plan that:
HOUSE BILL 1315 5
1 (1) is delivered or issued for delivery in the State;
2 (2) is written on an expense–incurred basis; and
3 (3) provides coverage for a family member of the insured.
4 (c) (1) A policy or plan subject to this section shall include under the family
5 member coverage a minimum package of child wellness services that are consistent with:
6 (i) public health policy;
7 (ii) professional standards; and
8 (iii) scientific evidence of effectiveness.
9 (2) The minimum package of child wellness services shall cover at least:
10 (i) all visits for and costs of childhood and adolescent
11 immunizations:
12 1. recommended by the Advisory Committee on
13 Immunization Practices of the Centers for Disease Control and Prevention; OR
14 2. RECOMMENDED BY THE AMERICAN ACADEMY OF
15 PEDIATRICS IN ITS CHILD AND ADOLESCENT IMMUNIZATION SCHEDULE BY AGE AS
16 OF DECEMBER 31, 2024;
17 (ii) visits for the collection of adequate samples, the first of which is
18 to be collected before 2 weeks of age, for hereditary and metabolic newborn screening and
19 follow–up between birth and 4 weeks of age;
20 (iii) universal hearing screening of newborns provided by a hospital
21 before discharge;
22 (iv) all visits for and costs of age–appropriate screening tests for
23 tuberculosis, anemia, lead toxicity, hearing, and vision as determined by the American
24 Academy of Pediatrics;
25 (v) all visits for obesity evaluation and management;
26 (vi) all visits for and costs of developmental screening as
27 recommended by the American Academy of Pediatrics;
28 (vii) a physical examination, developmental assessment, and
29 parental anticipatory guidance services at each of the visits required under items (i), (ii),
30 (iv), (v), and (vi) of this paragraph; and
6 HOUSE BILL 1315
1 (viii) any laboratory tests considered necessary by the physician as
2 indicated by the services provided under items (i), (ii), (iv), (v), (vi), or (vii) of this paragraph.
3 (f) (1) A policy or plan subject to this section may not impose a deductible on
4 the coverage required under this section.
5 (2) Each health insurance policy and certificate shall contain a notice of the
6 prohibition established by paragraph (1) of this subsection in a form approved by the
7 Commissioner.
8 (G) THE COMMISSIONER MAY ADOPT REGULATIONS NECESSARY TO CARRY
9 OUT SUBPARAGRAPH (C)(2)(I) OF THIS SECTION, CONSISTENT WITH FEDERAL
10 STATUTES, RULES, AND GUIDANCE IN EFFECT:
11 (1) ON DECEMBER 31, 2024; OR
12 (2) AT A LATER DATE TO ACCOUNT FOR ANY NEW VACCINES
13 RECOMMENDED BY THE CENTERS FOR DISEASE CONTROL AND PREVENTION’S
14 ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES AFTER DECEMBER 31, 2024.
15 SECTION 2. AND BE IT FURTHER ENACTED, That Section 1 of this Act shall
16 apply to all policies, contracts, and health benefit plans issued, delivered, or renewed in the
17 State on or after January 1, 2026.
18 SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect
19 January 1, 2026 June 1, 2025.
Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
Speaker of the House of Delegates.
________________________________________________________________________________
President of the Senate.
[DELETED: :CA      5     H H K R L M P A B S R A H C F c r t a i o a l a c a a t v c c a g r t h i c f c w s B  A  S  A  ( B  A S  A  (]
[DELETED:  H  B  A S  A  ( B  A  S  A  (  S T A 1  ( ( S a    ( T     1 A     2 A     3 U    ( T l i     1 H     2 C v     3 T v    ( T p h a c c i b c]
[DELETED: H 3    ( T p h c a m o 2 h o c A u    ( T r i p ( o t s a a c r a    ( I o i c   ( S t i    ( R b t C f D C a P    ( A o a b t U F a D A   ( S t a a v t i r i t C f D C a P   (  A (    ()  I]1    ()  M c e b t D i]2 c w t B t B o P a t B o N i r    )TCIH E IP’AC A RNS D O O M, C I T F SS RS A       .OD3,2 E   ]
[DELETED:  H      . A L D T A F A N R B T E F I O AD’ACINS D O O M R A3,2      ( A    ( R I    ( I p t    ( E f a i v a u p c p o i t v h n b a i a w a p o  ( T   ( S s   ( A f    ( H B D E 3 ;    ( I t A 1  ( I t  ( T p]
[DELETED: H 5   ( i   ( i   ( p  ( ( A m    ( p    ( p    ( s   ( T    ( a v f a c o c a a is      r b t A C o In      A B T M C OCAIS H D M C GEA  E 3,2 ;    ( v t f    ( u b    ( a v f a c o a s t f t A    ( a    ( a v f a c o d s a r    ( a p e d a a p (]
[DELETED:  H     ( a i  ( ( A t   ( E p e b p ( o t s i a f a b t C()TH O  S CI O T SN C W F)()S S ,     )D3,2 E       A L D T A F A N V B T E F I O A RNSDCPCIPD3,2 O M R E     S a S  S A B I F E T t A s t e J          G               ]


================================================================================

Raw Text:
HOUSE BILL 1315
J5, J1 5lr2486
By: Delegates Guzzone, Pena–Melnyk, Barnes, Crutchfield, Cullison, Embry, Fair,
Forbes, Harris, Hill, Kaiser, R. Lewis, Lopez, Martinez, Palakovich Carr,
Pruski, Ruff, Schindler, Smith, Stewart, Terrasa, Williams, and Woorman
Woorman, Alston, Bagnall, Bhandari, S. Johnson, Kerr, Rosenberg, Ross,
Taveras, White Holland, and Woods
Introduced and read first time: February 7, 2025
Assigned to: Health and Government Operations
Committee Report: Favorable with amendments
House action: Adopted
Read second time: March 6, 2025
CHAPTER ______
1 AN ACT concerning
2 Health Insurance – Vaccinations by Pharmacists and Health Insurance
3 Coverage for Child Wellness Services – Immunizations
4 FOR the purpose of altering the vaccinations that a pharmacist may administer, subject to
5 certain requirements, to an individual of at least a certain age; altering the
6 vaccinations included in the minimum package of child wellness services for which
7 certain health insurers and nonprofit health service plans are required to provide
8 coverage; and generally relating to health insurance coverage for child wellness
9 services immunizations.
10 BY repealing and reenacting, with amendments,
11 Article – Health Occupations
12 Section 12–508
13 Annotated Code of Maryland
14 (2021 Replacement Volume and 2024 Supplement)
15 BY repealing and reenacting, without amendments,
16 Article – Insurance
17 Section 15–817(a), (b), and (f)
18 Annotated Code of Maryland
19 (2017 Replacement Volume and 2024 Supplement)
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment. *hb1315*

2 HOUSE BILL 1315
1 BY repealing and reenacting, with amendments,
2 Article – Insurance
3 Section 15–817(c)
4 Annotated Code of Maryland
5 (2017 Replacement Volume and 2024 Supplement)
6 BY adding to
7 Article – Insurance
8 Section 15–817(g)
9 Annotated Code of Maryland
10 (2017 Replacement Volume and 2024 Supplement)
11 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
12 That the Laws of Maryland read as follows:
13 Article – Health Occupations
14 12–508.
15 (a) (1) Subject to paragraph (4) of this subsection, a pharmacist may order and
16 administer a vaccination to an individual who is at least 3 years old if:
17 (i) The vaccine is:
18 1. An influenza vaccine;
19 2. A COVID–19 vaccine; or
20 3. Used in response to a public health emergency;
21 (ii) The pharmacist has completed a practical training program of at
22 least 20 hours that is approved by the Accreditation Council for Pharmacy Education and
23 includes:
24 1. Hands–on injection techniques;
25 2. Clinical evaluation of indications and contraindications of
26 vaccines; and
27 3. The recognition and treatment of emergency reactions to
28 vaccines;
29 (iii) The pharmacist has a current certificate in basic
30 cardiopulmonary resuscitation;

HOUSE BILL 1315 3
1 (iv) The pharmacist has completed a minimum of 2 hours of
2 continuing pharmaceutical education related to immunizations that is approved by the
3 Accreditation Council for Pharmacy Education as part of the license renewal requirements
4 under § 12–309 of this title;
5 (v) The pharmacist complies with the record–keeping and reporting
6 requirements in paragraph (5) of this subsection and any corresponding regulations
7 adopted by the Board; and
8 (vi) If the vaccination is administered to an individual under the age
9 of 18 years, the pharmacist informs the child vaccination patient and adult caregiver who
10 is accompanying the child of the importance of well–child visits with a pediatric primary
11 care provider and refers the patient to a pediatric primary care provider when appropriate.
12 (2) Subject to paragraph (4) of this subsection, a pharmacist who has met
13 the requirement of paragraph (1)(ii) through (vi) of this subsection may administer to an
14 individual who is at least 7 years old a vaccination that is:
15 (i) Recommended by the Centers for Disease Control and
16 Prevention’s Advisory Committee on Immunization Practices; or
17 (ii) Approved or authorized by the U.S. Food and Drug
18 Administration.
19 (3) Subject to paragraph (4) of this subsection, a pharmacist who has met
20 the requirement of paragraph (1)(ii), (iii), and (iv) of this subsection may administer to an
21 adult a vaccination that is recommended in the Centers for Disease Control and
22 Prevention’s Health Information for International Travel.
23 (4) (I) A pharmacist shall administer a vaccination under paragraph
24 (1), (2), or (3) of this subsection under a written protocol that:
25 [(i)] 1. Is vaccine specific; and
26 [(ii)] 2. Meets criteria established by the Department, in
27 consultation with the Board, the Board of Physicians, and the Board of Nursing, in
28 regulation.
29 (II) THE RECOMMENDATIONS OF THE CENTERS FOR DISEASE
30 CONTROL AND PREVENTION’S ADVISORY COMMITTEE ON IMMUNIZATION
31 PRACTICES CITED IN THIS SECTION REFER TO FEDERAL STATUTES, RULES, AND
32 GUIDANCE IN EFFECT:
33 1. ON DECEMBER 31, 2024; OR

4 HOUSE BILL 1315
1 2. AT A LATER DATE TO ACCOUNT FOR ANY NEW
2 VACCINES RECOMMENDED BY THE CENTERS FOR DISEASE CONTROL AND
3 PREVENTION’S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES AFTER
4 DECEMBER 31, 2024.
5 (5) A pharmacist shall:
6 (i) Report all vaccinations administered by the pharmacist to the
7 ImmuNet Program established under § 18–109 of the Health – General Article;
8 (ii) If the vaccination has been administered in accordance with a
9 prescription, document at least one effort to inform the individual’s authorized prescriber
10 that the vaccination has been administered; and
11 (iii) Except for an influenza vaccination administered under
12 paragraph (1) of this subsection, if the authorized prescriber is not the individual’s primary
13 care provider or if the vaccination has not been administered in accordance with a
14 prescription, document at least one effort to inform the individual’s primary care provider
15 or other usual source of care that the vaccination has been administered.
16 (b) The Board shall:
17 (1) Set reasonable fees for the administration of vaccinations under this
18 section; and
19 (2) Adopt regulations that require a pharmacist to submit a registration
20 form to the Board that includes verification that the pharmacist:
21 (i) Has successfully completed a certification course approved by the
22 Board that included instruction in the guidelines and recommendations of the Centers for
23 Disease Control and Prevention regarding vaccinations IN EFFECT ON DECEMBER 31,
24 2024; and
25 (ii) Is certified in basic cardiopulmonary resuscitation and obtained
26 the certification through in–person classroom instruction.
27 Article – Insurance
28 15–817.
29 (a) In this section, “child wellness services” means preventive activities designed
30 to protect children from morbidity and mortality and promote child development.
31 (b) This section applies to each individual hospital or major medical insurance
32 policy, group or blanket health insurance policy, and nonprofit health service plan that:

HOUSE BILL 1315 5
1 (1) is delivered or issued for delivery in the State;
2 (2) is written on an expense–incurred basis; and
3 (3) provides coverage for a family member of the insured.
4 (c) (1) A policy or plan subject to this section shall include under the family
5 member coverage a minimum package of child wellness services that are consistent with:
6 (i) public health policy;
7 (ii) professional standards; and
8 (iii) scientific evidence of effectiveness.
9 (2) The minimum package of child wellness services shall cover at least:
10 (i) all visits for and costs of childhood and adolescent
11 immunizations:
12 1. recommended by the Advisory Committee on
13 Immunization Practices of the Centers for Disease Control and Prevention; OR
14 2. RECOMMENDED BY THE AMERICAN ACADEMY OF
15 PEDIATRICS IN ITS CHILD AND ADOLESCENT IMMUNIZATION SCHEDULE BY AGE AS
16 OF DECEMBER 31, 2024;
17 (ii) visits for the collection of adequate samples, the first of which is
18 to be collected before 2 weeks of age, for hereditary and metabolic newborn screening and
19 follow–up between birth and 4 weeks of age;
20 (iii) universal hearing screening of newborns provided by a hospital
21 before discharge;
22 (iv) all visits for and costs of age–appropriate screening tests for
23 tuberculosis, anemia, lead toxicity, hearing, and vision as determined by the American
24 Academy of Pediatrics;
25 (v) all visits for obesity evaluation and management;
26 (vi) all visits for and costs of developmental screening as
27 recommended by the American Academy of Pediatrics;
28 (vii) a physical examination, developmental assessment, and
29 parental anticipatory guidance services at each of the visits required under items (i), (ii),
30 (iv), (v), and (vi) of this paragraph; and

6 HOUSE BILL 1315
1 (viii) any laboratory tests considered necessary by the physician as
2 indicated by the services provided under items (i), (ii), (iv), (v), (vi), or (vii) of this paragraph.
3 (f) (1) A policy or plan subject to this section may not impose a deductible on
4 the coverage required under this section.
5 (2) Each health insurance policy and certificate shall contain a notice of the
6 prohibition established by paragraph (1) of this subsection in a form approved by the
7 Commissioner.
8 (G) THE COMMISSIONER MAY ADOPT REGULATIONS NECESSARY TO CARRY
9 OUT SUBPARAGRAPH (C)(2)(I) OF THIS SECTION, CONSISTENT WITH FEDERAL
10 STATUTES, RULES, AND GUIDANCE IN EFFECT:
11 (1) ON DECEMBER 31, 2024; OR
12 (2) AT A LATER DATE TO ACCOUNT FOR ANY NEW VACCINES
13 RECOMMENDED BY THE CENTERS FOR DISEASE CONTROL AND PREVENTION’S
14 ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES AFTER DECEMBER 31, 2024.
15 SECTION 2. AND BE IT FURTHER ENACTED, That Section 1 of this Act shall
16 apply to all policies, contracts, and health benefit plans issued, delivered, or renewed in the
17 State on or after January 1, 2026.
18 SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect
19 January 1, 2026 June 1, 2025.
Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
Speaker of the House of Delegates.
________________________________________________________________________________
President of the Senate.

[DELETED: :CA      5     H H K R L M P A B S R A H C F c r t a i o a l a c a a t v c c a g r t h i c f c w s B  A  S  A  ( B  A S  A  (]
[DELETED:  H  B  A S  A  ( B  A  S  A  (  S T A 1  ( ( S a    ( T     1 A     2 A     3 U    ( T l i     1 H     2 C v     3 T v    ( T p h a c c i b c]
[DELETED: H 3    ( T p h c a m o 2 h o c A u    ( T r i p ( o t s a a c r a    ( I o i c   ( S t i    ( R b t C f D C a P    ( A o a b t U F a D A   ( S t a a v t i r i t C f D C a P   (  A (    ()  I]1    ()  M c e b t D i]2 c w t B t B o P a t B o N i r    )TCIH E IP’AC A RNS D O O M, C I T F SS RS A       .OD3,2 E   ]
[DELETED:  H      . A L D T A F A N R B T E F I O AD’ACINS D O O M R A3,2      ( A    ( R I    ( I p t    ( E f a i v a u p c p o i t v h n b a i a w a p o  ( T   ( S s   ( A f    ( H B D E 3 ;    ( I t A 1  ( I t  ( T p]
[DELETED: H 5   ( i   ( i   ( p  ( ( A m    ( p    ( p    ( s   ( T    ( a v f a c o c a a is      r b t A C o In      A B T M C OCAIS H D M C GEA  E 3,2 ;    ( v t f    ( u b    ( a v f a c o a s t f t A    ( a    ( a v f a c o d s a r    ( a p e d a a p (]
[DELETED:  H     ( a i  ( ( A t   ( E p e b p ( o t s i a f a b t C()TH O  S CI O T SN C W F)()S S ,     )D3,2 E       A L D T A F A N V B T E F I O A RNSDCPCIPD3,2 O M R E     S a S  S A B I F E T t A s t e J          G               ]